Metraipolis › archive › dc_feedb2f4f392

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data — Europe PMC PMID:41514610

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41514610
DOI
10.3390/cancers18010098
License (as archived)
solo-consultazione
Archived
2026-11-07T09:02:30.929Z
SHA-256 of the archived text
165027e5b8db4ef02967f46d49656381642a7aa45a048bba92a028d5cc45c24d
Stable URL of this page
https://metraipolis.com/documento/dc_feedb2f4f392

How to cite

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data — Europe PMC PMID:41514610 — Europe PMC (en), https://europepmc.org/article/MED/41514610 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_feedb2f4f392 (Metraipolis archive dc_feedb2f4f392, sha256 165027e5b8db4ef02967f46d49656381642a7aa45a048bba92a028d5cc45c24d)
BibTeX
@misc{dcfeedb2f4f392,
  title = {Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data — Europe PMC PMID:41514610},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514610},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_feedb2f4f392; sha256 165027e5b8db4ef02967f46d49656381642a7aa45a048bba92a028d5cc45c24d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514610. Agents can read the archived copy with the MCP tool read_document.